APA (7th ed.) Citation

Greenhalf, W., & Büchler, M. W. (2014). Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. Journal of the National Cancer Institute, 106(1), . https://doi.org/10.1093/jnci/djt347

Chicago Style (17th ed.) Citation

Greenhalf, William, and Markus W. Büchler. "Pancreatic Cancer HENT1 Expression and Survival from Gemcitabine in Patients from the ESPAC-3 Trial." Journal of the National Cancer Institute 106, no. 1 (2014). https://doi.org/10.1093/jnci/djt347.

MLA (9th ed.) Citation

Greenhalf, William, and Markus W. Büchler. "Pancreatic Cancer HENT1 Expression and Survival from Gemcitabine in Patients from the ESPAC-3 Trial." Journal of the National Cancer Institute, vol. 106, no. 1, 2014, https://doi.org/10.1093/jnci/djt347.